EUVIMEDEUVIMED entdecken
Open Access

Interoperable Integration of a National Rare Disease Registry Into a Rare Eye Disease Data Warehouse: Implementation Study

Camille Beluffi Marin iD, Marilyne Oswald iD, Laura Ratenet iD, Matthieu Stoll iD, Kirsley Chennen iD, Hélène Dollfus iD

JMIR Medical Informatics · 2026

DOI: 10.2196/79378 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JMIR Medical Informatics, 2026. Verfasst von Camille Beluffi Marin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratoire de Génétique Médicale, UMR_S INSERM U1112, 1 rue Eugène Boeckel, Strasbourg, 67000, France, 33 03 68 85 36 60. Hauptthemen laut MEDLINE: Rare Diseases, Registries, Eye Diseases, Data Warehousing. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In France, clinical data on rare diseases are primarily collected through BaMaRa (Base Maladies Rares), a software platform used by national expert centers to populate the BNDMR (Banque Nationale de Données Maladies Rares), the French national rare disease data warehouse. BaMaRa ensures standardized and structured data collection across all rare disease networks, with a focus on care coordination and epidemiological reporting. In 2024, FREDD (French Rare Eye Disease Database), a health data warehouse dedicated to rare eye diseases, was developed within the framework of the third French National Rare Disease Plan by the SENSGENE sector. Despite overlapping datasets, there is no native interoperability between BaMaRa and FREDD, requiring the development of a dedicated, traceable pipeline to transform BaMaRa exports into data suitable for inclusion in FREDD. This transformation involves complex business rules to address structural, semantic, and specific differences between the two systems.

Objective

This study aims to describe the design and implementation of a robust data transformation pipeline that enables the automated conversion of BaMaRa clinical records into a structured dataset aligned with the FREDD data model. The primary goal is to ensure that the data remain semantically consistent and reusable for the secondary use of health data.

Methods

We developed a Python-based application called FREDDEX that integrates several configuration files and encodes the domain-specific business rules required to align BaMaRa data with the FREDD schema. These rules include patient filtering, mapping of variable names and values, management of multisource redundancy, and prevention of overwriting. The system was designed to be modular, auditable, and usable by clinical data managers with minimal technical expertise.

Results

FREDDEX was tested and validated on a BaMaRa export of 1000 real patients from Strasbourg University Hospital. The tool successfully filtered and created 641 patient profiles in FREDD, with a 99% success rate for attempted imports and full concordance (100%) for directly mapped and inferred variables. Genetic data reconstruction was confirmed on a random sample of 30 patients with genetic information, showing 100% accuracy, and multidiagnostic blocks were correctly handled in all manually reviewed cases. Beyond validation, FREDDEX processed up to 5000 patient records, enabling the rapid onboarding of new clinical sites and significantly reducing manual curation time, while runtime and memory usage demonstrated near-linear scaling. Importantly, the tool established a facilitated reproducible framework adaptable to other rare disease contexts and interoperable with national and European platforms, such as European Reference Network-EYE.

Conclusions

This work demonstrates that transforming structured national rare disease registry data into a research-oriented health data warehouse is feasible when clinical business rules are explicitly formalized within an auditable extract-transform-load framework. Beyond the FREDD use case, this approach illustrates how interoperability between care-based and research infrastructures can be operationalized in rare diseases while preserving semantic integrity and regulatory compliance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rare DiseasesRegistriesEye DiseasesData WarehousingHumansFranceDatabases, FactualSoftware

Stichwörter der Autor:innen

BaMaRa (French national registry for rare diseases)data interoperabilityextract-transform-loadhealth data warehouserare diseasessecondary use of health data

Autor:innen und Institutionen

  • Laboratoire de Génétique Médicale, UMR_S INSERM U1112, 1 rue Eugène Boeckel, Strasbourg, 67000, France, 33 03 68 85 36 60.
  • FSMR SENSGENE, Coordination Center, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
  • FSMR SENSGENE, Centre de Référence Pour les Affections Rares en Génétique Ophtalmologique (CRMR CARGO), Institut de Génétique Médicale d'Alsace (IGMA), ERN-EYE, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.

ORCID-Profile: Camille Beluffi Marin, Marilyne Oswald, Laura Ratenet, Matthieu Stoll, Kirsley Chennen, Hélène Dollfus

Zitieren

APA

Beluffi Marin, C., Oswald, M., Ratenet, L., Stoll, M., Chennen, K., & Dollfus, H. (2026). Interoperable Integration of a National Rare Disease Registry Into a Rare Eye Disease Data Warehouse: Implementation Study. JMIR Medical Informatics. https://doi.org/10.2196/79378

Vancouver

Beluffi Marin C, Oswald M, Ratenet L, Stoll M, Chennen K, Dollfus H. Interoperable Integration of a National Rare Disease Registry Into a Rare Eye Disease Data Warehouse: Implementation Study. JMIR Medical Informatics. 2026. doi:10.2196/79378

BibTeX
@article{BeluffiMarin2026,
  author = {Beluffi Marin, Camille and Oswald, Marilyne and Ratenet, Laura and Stoll, Matthieu and Chennen, Kirsley and Dollfus, Hélène},
  title = {Interoperable Integration of a National Rare Disease Registry Into a Rare Eye Disease Data Warehouse: Implementation Study},
  journal = {JMIR Medical Informatics},
  year = {2026},
  doi = {10.2196/79378}
}
Kostenlos starten →